InvestorWire NewsRoom

Article

Cannabis Strategic Ventures Inc. (NUGS) Strengthens Foothold as Mounting Numbers Support Cannabis Legalization
January 6, 2022

Cannabis Strategic Ventures Inc. (NUGS) Strengthens Foothold as Mounting Numbers Support Cannabis Legalization

  • An estimated 91% of U.S. adults (91%) say either that marijuana should be legal for medical and recreational use or that it should be legal for medical use only
  • While cannabis remains an illegal substance federally, a growing number of states have legalized the substance
  • An emerging leader in the U.S. cannabis marketplace, NUGS’ vision is to acquire, scale assets in the legal cannabis market

A vast majority of adults in the United States say that marijuana should be legal for either medical and recreational use or at least for medical use, according to a recent Pew Research Center report (https://ibn.fm/zqnb9). Companies such as Cannabis Strategic Ventures (OTC: NUGS) look to those numbers in anticipation of a promising future.

“As more states, including Virginia and New York, continue to legalize marijuana, an overwhelming share of U.S. adults (91%) say either that marijuana should be legal for medical and recreational use (60%) or that it should be legal for medical use only (31%),” the Power Research Center article notes. “Fewer than one in ten (8%) say marijuana should not be legal for use by adults.”

While cannabis remains an illegal substance federally, a growing number of states have legalized the substance. “Lawmakers across the U.S. proved again in 2021 that marijuana reform will continue to advance on the state level despite the recalcitrance of Congress to end federal prohibition,” a “Marijuana Moment” article states (https://ibn.fm/fMloj). “As more eyes turn to 2022 legislative sessions, a report from NORML that was released on Monday details advocates’ progress on the cannabis front this year in more than 25 states, where over 50 pieces of marijuana reform legislation were enacted.

Most notably, legislatures and governors in five states enacted recreational legalization — a notable trend given that the reform has historically been decided by voters as ballot initiatives,” the article continued. “But 2021 has also seen more modest policy changes related to medical cannabis, decriminalization and social equity. ‘State lawmakers took unprecedented steps this year to repeal marijuana prohibition laws and to provide relief to those millions of Americans who have suffered as a result of them,’ NORML Deputy Director Paul Armentano said.”

As growing numbers of Americans of across a variety of ages and political affiliations support the legalization of cannabis, companies that are establishing a strong foothold in the industry stand to benefit. Cannabis Strategic Ventures is one of those companies. An emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator, the company’s vision is to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration. 

As part of that vision, Cannabis Strategic Ventures owns NUGS Farm North, a six-acre cannabis farm in Northern California. In addition, the company is committed to taking other steps to strengthen its position in the growing market, including working toward taking operational control of each license. The company also recently celebrated the opening of its cannabis dispensary and is looking to deploy another license to establish an indoor cultivation facility with capacity to produce two to three pounds of premium exotic cannabis flower per light per harvest. 

For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).